Newsletter | September 5, 2019

09.05.19 -- How to Maintain Autonomy in Your Biomanufacturing Partnership

*|Biomanufacturing Partnerships|*

How to Maintain Autonomy in Your Biomanufacturing Partnership

Collaborating with a CDMO can help you bring your drug to market faster. But handing over vital information about your product can make it feel like you are giving up – or even losing power over – your own project.

That’s why it’s important to find a partner  who can alleviate the risks associated with drug development, while also knowing how to work in a way that protects your intellectual property. 

How can you tell if your CDMO is prepared to offer that level of commitment to your project? Read this article to discover the four business practices you should look for and find out what you can do to ensure a smooth transfer of knowledge.

Read the Article

Fast Trak: Services from molecule to market

GE’s Fast Trak services will help you to increase productivity, reduce costs, and bring your products to market faster. With a comprehensive portfolio of services including cGMP manufacturing, process development, and training, Fast Trak gives you the tools and know-how you need to solve biomanufacturing challenges and optimize your process.
Check out the below apps provided by GE Healthcare Life Sciences to discover how others like you are solving their biomanufacturing challenges.
Why did I get this? From time to time, we hand-pick articles that we feel may be of interest to you based on the content you’ve read on Cell & Gene. We hope you enjoy these pieces and we welcome feedback on how we can improve our editorial offerings.
This newsletter is being sent to {{lead.Email Address}}. If you need to update your preferences, please visit your user profile. To cancel your subscription to the newsletter, please opt out here.

© Copyright 2019 {{my.Member_Addr}}. All rights reserved. All product names contained herein are the trademarks of their respective holders.